chr20-64048609-C-G
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_018419.3(SOX18):c.712G>C(p.Glu238Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000182 in 1,100,096 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000018 ( 0 hom. )
Consequence
SOX18
NM_018419.3 missense
NM_018419.3 missense
Scores
2
10
7
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 6.69
Publications
1 publications found
Genes affected
SOX18 (HGNC:11194): (SRY-box transcription factor 18) This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of the cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. This protein plays a role in hair, blood vessel, and lymphatic vessel development. Mutations in this gene have been associated with recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. [provided by RefSeq, Jul 2008]
SOX18 Gene-Disease associations (from GenCC):
- hypotrichosis-lymphedema-telangiectasia-renal defect syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- hypotrichosis-lymphedema-telangiectasia syndromeInheritance: AR, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypotrichosis-lymphedema-telangiectasia syndrome (grouping)Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1100096Hom.: 0 Cov.: 31 AF XY: 0.00000191 AC XY: 1AN XY: 522302 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
1100096
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
522302
show subpopulations
African (AFR)
AF:
AC:
0
AN:
22364
American (AMR)
AF:
AC:
0
AN:
7946
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
13974
East Asian (EAS)
AF:
AC:
0
AN:
25128
South Asian (SAS)
AF:
AC:
0
AN:
27340
European-Finnish (FIN)
AF:
AC:
0
AN:
22780
Middle Eastern (MID)
AF:
AC:
0
AN:
2950
European-Non Finnish (NFE)
AF:
AC:
2
AN:
933416
Other (OTH)
AF:
AC:
0
AN:
44198
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
PhyloP100
PrimateAI
Pathogenic
D
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of glycosylation at P237 (P = 0.208);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.